Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W Boyd

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Leukemia & Lymphoma|September 25, 2014
A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemiaSimon Z He, Samantha Busfield, David S Ritchie, et al.
Scientific Reports|March 22, 2019
A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastomaBrett W Stringer, Bryan W Day, Rochelle C J D'Souza, et al.
Scientific Reports|January 23, 2020
Publisher Correction: A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastomaBrett W Stringer, Bryan W Day, Rochelle C J D'Souza, et al.
Cancer Cell|February 16, 2013
EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiformeBryan W Day, Brett W Stringer, Fares Al-Ejeh, et al.
Acta Neuropathologica|August 30, 2019
The dystroglycan receptor maintains glioma stem cells in the vascular nicheBryan W Day, Justin D Lathia, Zara C Bruce, et al.
Neuro-Oncology|September 11, 2019
Simultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophoreYi Chieh Lim, Kathleen S Ensbey, Carolin Offenhäuser, et al.
International Journal of Epidemiology|September 29, 2014
DataSHIELD: taking the analysis to the data, not the data to the analysisAmadou Gaye, Yannick Marcon, Julia Isaeva, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Leukemia & Lymphoma|September 25, 2014
A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemiaSimon Z He, Samantha Busfield, David S Ritchie, et al.
Scientific Reports|March 22, 2019
A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastomaBrett W Stringer, Bryan W Day, Rochelle C J D'Souza, et al.
Scientific Reports|January 23, 2020
Publisher Correction: A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastomaBrett W Stringer, Bryan W Day, Rochelle C J D'Souza, et al.
Cancer Cell|February 16, 2013
EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiformeBryan W Day, Brett W Stringer, Fares Al-Ejeh, et al.
Acta Neuropathologica|August 30, 2019
The dystroglycan receptor maintains glioma stem cells in the vascular nicheBryan W Day, Justin D Lathia, Zara C Bruce, et al.
Neuro-Oncology|September 11, 2019
Simultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophoreYi Chieh Lim, Kathleen S Ensbey, Carolin Offenhäuser, et al.
International Journal of Epidemiology|September 29, 2014
DataSHIELD: taking the analysis to the data, not the data to the analysisAmadou Gaye, Yannick Marcon, Julia Isaeva, et al.
Pageof 7